Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical spectrum of urine cultures positive for ESBL-producing Escherichia coli in hospitalized patients and impact on antibiotic use.
Lepeule R, Leflon-Guibout V, Vanjak D, Zahar JR, Lafaurie M, Besson C, Lefort A; Groupe des Référents en Infectiologie d’Île-de-France (GRIF). Lepeule R, et al. Among authors: lafaurie m. Med Mal Infect. 2014 Dec;44(11-12):530-4. doi: 10.1016/j.medmal.2014.09.004. Epub 2014 Oct 11. Med Mal Infect. 2014. PMID: 25311839
Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year study.
Denis B, Lafaurie M, Donay JL, Fontaine JP, Oksenhendler E, Raffoux E, Hennequin C, Allez M, Socie G, Maziers N, Porcher R, Molina JM. Denis B, et al. Among authors: lafaurie m. Int J Infect Dis. 2015 Oct;39:1-6. doi: 10.1016/j.ijid.2015.07.010. Epub 2015 Jul 17. Int J Infect Dis. 2015. PMID: 26189774 Free article.
A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial.
Huttner BD, de Lastours V, Wassenberg M, Maharshak N, Mauris A, Galperine T, Zanichelli V, Kapel N, Bellanger A, Olearo F, Duval X, Armand-Lefevre L, Carmeli Y, Bonten M, Fantin B, Harbarth S; R-Gnosis WP3 study group. Huttner BD, et al. Clin Microbiol Infect. 2019 Jul;25(7):830-838. doi: 10.1016/j.cmi.2018.12.009. Epub 2019 Jan 4. Clin Microbiol Infect. 2019. PMID: 30616014 Free article. Clinical Trial.
Continuous infusion of ceftolozane/tazobactam is associated with a higher probability of target attainment in patients infected with Pseudomonas aeruginosa.
Pilmis B, Petitjean G, Lesprit P, Lafaurie M, El Helali N, Le Monnier A; on behalf the ATB PK/PD study group. Pilmis B, et al. Among authors: lafaurie m. Eur J Clin Microbiol Infect Dis. 2019 Aug;38(8):1457-1461. doi: 10.1007/s10096-019-03573-4. Epub 2019 May 9. Eur J Clin Microbiol Infect Dis. 2019. PMID: 31073653
Efficacy of cefoxitin versus carbapenem in febrile male urinary tract infections caused by extended spectrum beta-lactamase-producing Escherichia coli: a multicenter retrospective cohort study with propensity score analysis.
Senard O, Lafaurie M, Lesprit P, Nguyen Y, Lescure X, Therby A, Fihman V, Oubaya N, Lepeule R. Senard O, et al. Among authors: lafaurie m. Eur J Clin Microbiol Infect Dis. 2020 Jan;39(1):121-129. doi: 10.1007/s10096-019-03701-0. Epub 2019 Sep 11. Eur J Clin Microbiol Infect Dis. 2020. PMID: 31512147
183 results